244 related articles for article (PubMed ID: 35708503)
21. Somatic instability of the expanded GAA repeats in Friedreich's ataxia.
Long A; Napierala JS; Polak U; Hauser L; Koeppen AH; Lynch DR; Napierala M
PLoS One; 2017; 12(12):e0189990. PubMed ID: 29261783
[TBL] [Abstract][Full Text] [Related]
22. Activating frataxin expression by repeat-targeted nucleic acids.
Li L; Matsui M; Corey DR
Nat Commun; 2016 Feb; 7():10606. PubMed ID: 26842135
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel missense mutation in Friedreich's ataxia -FXN
Clark E; Strawser C; Schadt K; Lynch DR
Ann Clin Transl Neurol; 2019 Apr; 6(4):812-816. PubMed ID: 31020006
[TBL] [Abstract][Full Text] [Related]
24. The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia.
Bit-Avragim N; Perrot A; Schöls L; Hardt C; Kreuz FR; Zühlke C; Bubel S; Laccone F; Vogel HP; Dietz R; Osterziel KJ
J Mol Med (Berl); 2001; 78(11):626-32. PubMed ID: 11269509
[TBL] [Abstract][Full Text] [Related]
25. Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3.
Chan PK; Torres R; Yandim C; Law PP; Khadayate S; Mauri M; Grosan C; Chapman-Rothe N; Giunti P; Pook M; Festenstein R
Hum Mol Genet; 2013 Jul; 22(13):2662-75. PubMed ID: 23474817
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells.
Vilema-Enríquez G; Quinlan R; Kilfeather P; Mazzone R; Saqlain S; Del Molino Del Barrio I; Donato A; Corda G; Li F; Vedadi M; Németh AH; Brennan PE; Wade-Martins R
J Biol Chem; 2020 Dec; 295(52):17973-17985. PubMed ID: 33028632
[TBL] [Abstract][Full Text] [Related]
27. Excision of Expanded GAA Repeats Alleviates the Molecular Phenotype of Friedreich's Ataxia.
Li Y; Polak U; Bhalla AD; Rozwadowska N; Butler JS; Lynch DR; Dent SYR; Napierala M
Mol Ther; 2015 Jun; 23(6):1055-1065. PubMed ID: 25758173
[TBL] [Abstract][Full Text] [Related]
28. Neurobehavioral deficits of mice expressing a low level of G127V mutant frataxin.
Fil D; Conley RL; Zuberi AR; Lutz CM; Gemelli T; Napierala M; Napierala JS
Neurobiol Dis; 2023 Feb; 177():105996. PubMed ID: 36638893
[TBL] [Abstract][Full Text] [Related]
29. Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice.
Kilikevicius A; Wang J; Shen X; Rigo F; Prakash TP; Napierala M; Corey DR
RNA Biol; 2022; 19(1):364-372. PubMed ID: 35289725
[TBL] [Abstract][Full Text] [Related]
30. Influence of Friedreich ataxia GAA noncoding repeat expansions on pre-mRNA processing.
Baralle M; Pastor T; Bussani E; Pagani F
Am J Hum Genet; 2008 Jul; 83(1):77-88. PubMed ID: 18597733
[TBL] [Abstract][Full Text] [Related]
31. Complete FXN deletion in a patient with Friedreich's ataxia.
van den Ouweland AM; van Minkelen R; Bolman GM; Wouters CH; Becht-Noordermeer C; Deelen WH; Deelen-Manders JM; Ippel EP; Saris J; Halley DJ
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1015-8. PubMed ID: 22691228
[TBL] [Abstract][Full Text] [Related]
32. Progressive GAA expansions in dorsal root ganglia of Friedreich's ataxia patients.
De Biase I; Rasmussen A; Endres D; Al-Mahdawi S; Monticelli A; Cocozza S; Pook M; Bidichandani SI
Ann Neurol; 2007 Jan; 61(1):55-60. PubMed ID: 17262846
[TBL] [Abstract][Full Text] [Related]
33. G-rich motifs within phosphorothioate-based antisense oligonucleotides (ASOs) drive activation of FXN expression through indirect effects.
Wang F; Calvo-Roitberg E; Rembetsy-Brown JM; Fang M; Sousa J; Kartje ZJ; Krishnamurthy PM; Lee J; Green MR; Pai AA; Watts JK
Nucleic Acids Res; 2022 Dec; 50(22):12657-12673. PubMed ID: 36511872
[TBL] [Abstract][Full Text] [Related]
34. SINEUP non-coding RNAs rescue defective frataxin expression and activity in a cellular model of Friedreich's Ataxia.
Bon C; Luffarelli R; Russo R; Fortuni S; Pierattini B; Santulli C; Fimiani C; Persichetti F; Cotella D; Mallamaci A; Santoro C; Carninci P; Espinoza S; Testi R; Zucchelli S; Condò I; Gustincich S
Nucleic Acids Res; 2019 Nov; 47(20):10728-10743. PubMed ID: 31584077
[TBL] [Abstract][Full Text] [Related]
35. Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia.
Evans-Galea MV; Lockhart PJ; Galea CA; Hannan AJ; Delatycki MB
Discov Med; 2014 Jan; 17(91):25-35. PubMed ID: 24411698
[TBL] [Abstract][Full Text] [Related]
36. Molecular approaches for the treatment and prevention of Friedreich's ataxia.
Yang W; Thompson B; Kwa FAA
Drug Discov Today; 2022 Mar; 27(3):866-880. PubMed ID: 34763067
[TBL] [Abstract][Full Text] [Related]
37. Altered nucleosome positioning at the transcription start site and deficient transcriptional initiation in Friedreich ataxia.
Chutake YK; Costello WN; Lam C; Bidichandani SI
J Biol Chem; 2014 May; 289(22):15194-202. PubMed ID: 24737321
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation in Friedreich ataxia silences expression of frataxin isoform E.
Rodden LN; Gilliam KM; Lam C; Rojsajjakul T; Mesaros C; Dionisi C; Pook M; Pandolfo M; Lynch DR; Blair IA; Bidichandani SI
Sci Rep; 2022 Mar; 12(1):5031. PubMed ID: 35322126
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic promoter silencing in Friedreich ataxia is dependent on repeat length.
Chutake YK; Lam C; Costello WN; Anderson M; Bidichandani SI
Ann Neurol; 2014 Oct; 76(4):522-8. PubMed ID: 25112975
[TBL] [Abstract][Full Text] [Related]
40. Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms.
Li H; Gakh O; Smith DY; Ranatunga WK; Isaya G
J Biol Chem; 2013 Feb; 288(6):4116-27. PubMed ID: 23269675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
